| abstract |
Provided is a flurbiprofen injection, comprising flurbiprofen, phosphate, and water for injection. The molar ratio of the phosphate to flurbiprofen is 0.1:1-10:1, and preferably is 0.25:1-5:1 and 0.25:1-2:1, and further preferably is 0.5:1-1:1, and the phosphate preferably is disodium hydrogen phosphate. The provided flurbiprofen injection can remain stable at the room temperature for 12 months, and the content of degradation impurities generated in strong light exposure is obviously reduced; moreover, no irritation during intravenous injection. |